Advances in the Treatment of Renal Cell Carcinoma
| Advances in the Treatment of Renal Cell Carcinoma |
| Autore | Reynolds Paul |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (221 p.) |
| Soggetto topico | Medicine |
| Soggetto non controllato |
artesunate (ART)
autophagy biomarker biomarkers ccRCC chloroquine clear cell renal cell carcinoma cysteine cathepsin inhibitors cysteine cathepsins evolution evolutionary trajectory ferroptosis genomic signature growth inhibition hydroxychloroquine immune checkpoint inhibitors immune-based combination therapies immunotherapy individualization kidney cancer lysosome metastatic metastatic renal cell carcinoma mRCC network meta-analysis PD-L1 predictive RCC reactive oxygen species (ROS) renal cancer renal cell cancer renal cell carcinoma renal cell carcinoma (RCC) ROC-325 second line therapy soluble factors sunitib resistance TKIs Traditional Chinese Medicine (TCM) transcriptomic analysis treatment tyrosine kinase inhibitors |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557615503321 |
Reynolds Paul
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
New Therapies of Liver Diseases
| New Therapies of Liver Diseases |
| Autore | Toniutto Pierluigi |
| Pubbl/distr/stampa | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica | 1 online resource (236 p.) |
| Soggetto topico | Public health and preventive medicine |
| Soggetto non controllato |
acute-on-chronic liver failure
acute-on-chronic liver failure (ACLF) alcoholic hepatitis alpha-fetoprotein ammonia anti-mineralocorticoids antivirals ascites autoantibodies bleeding cholangiocarcinoma cirrhosis cirrhotic ascites clinical trials colorectal cancer metastases decompensated cirrhosis decompensation effective hypovolemia Farnesoid X Receptor (FXR) agonist functional cure furosemide HBV HDV hepatocellular carcinoma human albumin humoral response immunosuppressant immunotherapy infection liver cancer liver injury liver transplantation liver transplantation (LT) loop diuretics Milan criteria n/a non-selective beta-blockers Pan-Peroxisome Proliferator-Activated Receptor (PPAR) agonists pharmacology portal hypertension portal-systemic shunt primary biliary cholangitis primary biliary cholangitis (PBC) primary sclerosing cholangitis (PSC) real-world rifaximin SARS-CoV-2 second line therapy solid organ transplantation statins survival survival rate systemic treatment targeted therapy TIPS tolvaptan treatment response unresectable hepatocellular carcinoma ursodeoxycholic acid ursodeoxycholic acid (UDCA) vaccination vaptans varices vigilance |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910566457403321 |
Toniutto Pierluigi
|
||
| Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||